Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA19-9) are common markers used in clinics, with CEA rising in later gastric cancer stages and CA19-9 elevated in pancreatic cancer [28]. This evidence concerns the gene CEACAM5 and pancreatic neoplasm.